SE8002602L - DIAGNOSTIC PROCEDURE - Google Patents

DIAGNOSTIC PROCEDURE

Info

Publication number
SE8002602L
SE8002602L SE8002602A SE8002602A SE8002602L SE 8002602 L SE8002602 L SE 8002602L SE 8002602 A SE8002602 A SE 8002602A SE 8002602 A SE8002602 A SE 8002602A SE 8002602 L SE8002602 L SE 8002602L
Authority
SE
Sweden
Prior art keywords
serum
dna
cancer
diagnostic procedure
human beings
Prior art date
Application number
SE8002602A
Other languages
Unknown language ( )
Swedish (sv)
Inventor
S T Crooke
L Galvan
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8002602L publication Critical patent/SE8002602L/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4704—Inhibitors; Supressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]

Abstract

Inhibitor protein X in its substantially pure form having the following characterising properties: (i) it is a protein isolatable from human blood serum; (ii) it has a molecular weight of about 64,000 daltons and a Pl of 5.9; (iii) it inhibits bleomycin-induced degradation of PM-2 DNA by binding to the DNA; and (iv) it is found in lower concentrations in the serum of human beings having cancer than in the serum of cancer-free human beings. h
SE8002602A 1979-04-10 1980-04-03 DIAGNOSTIC PROCEDURE SE8002602L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2873279A 1979-04-10 1979-04-10

Publications (1)

Publication Number Publication Date
SE8002602L true SE8002602L (en) 1980-12-09

Family

ID=21845111

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8002602A SE8002602L (en) 1979-04-10 1980-04-03 DIAGNOSTIC PROCEDURE

Country Status (24)

Country Link
JP (1) JPS55143441A (en)
KR (1) KR830002502A (en)
AR (1) AR222700A1 (en)
AT (1) AT365343B (en)
AU (1) AU536522B2 (en)
BE (1) BE882669A (en)
CH (1) CH644453A5 (en)
DE (1) DE3013837A1 (en)
DK (1) DK149980A (en)
ES (1) ES490396A0 (en)
FI (1) FI801078A (en)
FR (1) FR2454099A1 (en)
GB (1) GB2047712B (en)
GR (1) GR67692B (en)
HU (1) HU183122B (en)
IE (1) IE49981B1 (en)
IL (1) IL59772A (en)
IT (1) IT1143135B (en)
LU (1) LU82345A1 (en)
NL (1) NL8002094A (en)
NO (1) NO801018L (en)
PH (1) PH15637A (en)
SE (1) SE8002602L (en)
ZA (1) ZA802141B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524644A1 (en) * 1985-07-10 1987-01-15 Heyl Chem Pharm UNDULIN AND ITS PEPTIDE FRAGMENTS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE

Also Published As

Publication number Publication date
AT365343B (en) 1982-01-11
BE882669A (en) 1980-10-06
PH15637A (en) 1983-03-11
IL59772A0 (en) 1980-06-30
IE800693L (en) 1980-10-10
GR67692B (en) 1981-09-07
IT1143135B (en) 1986-10-22
JPS55143441A (en) 1980-11-08
FI801078A (en) 1980-10-11
NL8002094A (en) 1980-10-14
ZA802141B (en) 1981-04-29
LU82345A1 (en) 1980-12-16
DE3013837A1 (en) 1980-10-30
HU183122B (en) 1984-04-28
GB2047712B (en) 1983-02-23
ATA195780A (en) 1981-05-15
ES8103380A1 (en) 1981-02-16
IT8048370A0 (en) 1980-04-09
IE49981B1 (en) 1986-01-22
AU5719380A (en) 1980-10-16
DK149980A (en) 1980-10-11
FR2454099B1 (en) 1984-01-27
AR222700A1 (en) 1981-06-15
ES490396A0 (en) 1981-02-16
GB2047712A (en) 1980-12-03
IL59772A (en) 1983-05-15
FR2454099A1 (en) 1980-11-07
CH644453A5 (en) 1984-07-31
NO801018L (en) 1980-10-13
AU536522B2 (en) 1984-05-10
KR830002502A (en) 1983-05-30

Similar Documents

Publication Publication Date Title
DE69231473D1 (en) IMMUNOCHEMICAL DETECTION OF END PRODUCTS OF ADVANCED GLYCOSYLATION IN VIVO
SE8000469L (en) TISSUE BINDING AND PROCEDURE FOR ITS MANUFACTURING AND USING THE BINDING AGENT
DK0733067T3 (en) N-terminally chemically modified protein preparations and methods
SE8601135L (en) CHEMICAL MODIFIED HYALURONIC ACID PREPARATION AND METHOD FOR THE EXTRACTION OF ANIMAL TREATMENT
DK524187A (en) AMINO ACID RELATED AGENTS FOR DELIVERY TO SPECIFIC BIOLOGICAL WEBSITES
DE69131847T2 (en) USE OF COPPER CONTAINING COPPER TO ACCELERATE Wounds Healing
DE3587941T2 (en) DEVICE FOR PROVISIONAL REPERFUSION TREATMENT OF HEART ATTACK SYMPTOMS.
DE3880047D1 (en) COMPOSITION OF AN ADDITION.
ZA872166B (en) Synthetic htlv-iii peptides,compositions and uses thereof
KR890007750A (en) DNA clone of human tissue factor inhibitor
IT7829543A0 (en) METHOD AND COMPOSITIONS FOR THE DIRECT DETERMINATION OF IRON IN BLOOD SERUM.
DE68921979D1 (en) ANTIBODIES FOR ANTILYMPHOCYTIC ANTIBODY THERAPY.
ATE13767T1 (en) PROTEIN (PP16), METHODS FOR ITS ENCOURAGEMENT AND RECOVERY AND ITS USE.
ES511982A0 (en) "PROCEDURE FOR THE PREPARATION OF PLASMINOGEN PRACTICALLY FREE FROM HEPATITIS VIRUSES".
DE69129747T2 (en) BRINGING PROTEINS IN SOLUTION IN ACTIVE FORM
DK0536177T3 (en) Thrombin inhibitors based on the amino acid sequence of hirudin
SE8002602L (en) DIAGNOSTIC PROCEDURE
NO173336C (en) Process for Isolating Basement Membrane Proteins from Human or Animal Tissue and Using the Protein Obtained
FI885025A (en) KOAGULATIONSHAEMMANDE PROTEIN PP4-X, DESS FRAMSTAELLNING OCH ANVAENDNING.
ES8505915A1 (en) Perfumery compounds and their preparation.
ATE77102T1 (en) PROCESSES FOR PURIFICATION AND PASTEURIZATION OF UROKINASE.
NO864382D0 (en) MEASURES FOR IMPROVING PROTEIN ABSORPTION.
IT1116518B (en) COMPOSITION TO PREVENT OR TREAT THE PIG DYSENTERY AND RELATED PROCEDURE FOR USE
ATE16809T1 (en) USE OF AN AGENT DERIVED FROM BLOOD SERUM TO STABILIZE PROSTAGLANDINS.
DE3586795D1 (en) ABSORPTION IMPROVERS FOR PROTEINS.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8002602-4